PECULIARITIES OF CYTOKINES AND THEIR PROGNOSTIC VALUE IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
Abstract
Introduction. Cytokines are important to take part in immunogenesis and progression of glomerulonephritis (GN), therefore the analysis of these indices in dependence of type of GN forms as prognosys results of treatment.
Aim of the work is to determine the peculiarities of pro-inflammatory cytokines (TNFα, MCP-1, IL-17, -18, -23) and anti-inflammatory TGF- β1 and their association with form GN with nephritic syndrome (NS) and possibility use cytokines as prognostic markers.
Materials and methods. Using IFA, the level of the above mentioned cytokines was studied in the blood serum of 117 patients with proliferative (33) and non-proliferative (84) CGN, NS forms. There was also analyzed the changes of these indices in the patients with subsequent clinical laboratory remission (59) and patients without one (58).
Results. The GN, NS patients showed statistically higher level of the pro- inflammatory cytokines – TNFα, MCP-1, IL-17 (with more high indices last one in the proliferative forms of GN, and IL-17 in nonsensitive to immunotherapy patients). High level profibrogenic TGFβ, and the ratio TNFα /TGFβ reflect the prevalence of anti-inflammatory reactions and high activity of monocytes - macrophages and T-helpers17. The positive effect of the treatment associates with the statistically decreased TNFα, MCP-1 and TGFβ1 levels in the patients with proliferative forms GN; the TGFβ1 - for patients with non-proliferative GN forms.
Conclusion. The changes cytokine profiles may be use as predictors of results the immunosuppressive therapy.
Downloads
References
Бездетко Т. В. Особенности иммунологического гомеостаза больных латентной формы хронического гломерулонефрита / Т. В. Бездетко // Медицина - сегодня и завтра. – 2000. – № 2. – С. 31–33.
Бобкова И. Н. Клиническое значение определения в моче маркеров эндотелиальной дисфункции и факторов ангиогенеза в оценке тубулоинтерстициального фиброза при хроническом гломерулонефрите / И. Н. Бобкова [и др.] // Терапевтический архив. – 2007. - № 6. – С. 27-30.
Вашурина Т. В. Цитокины и адгезивные молекулы в патогенезе первичного хронического гломерулонефрита : автореф. дис. … канд. мед. наук : 14. 01. 37 – Нефрологія / Т. В. Вашурина. – М., 2002. – 27 с.
Зубова С. Г. Молекулярные механизмы действия фактора некроза опухолей б и трансформирующего фактора роста в в процессе ответа макрофага на активацию / С. Г. Зубова, В. Б. Окулов // Иммунология. - 2001. - № 5. – С. 18-22.
Колесник М. О. Мікофенолату мофетил : перспективи застосування у нефрологічній практиці / М. О. Колесник, І. І. Лапчинська // Ліки України. – 1999. - № 5-6. - С. 3-6.
Мухин Н. А. Индуцируемые протеинурией механизмы ремоделирования тубулоинтерстиция и возможности нефропротекции при гломерулонефрите / И. В. Мухин Л. В. Козловская., И. Н. Бобкова [и др.] // Вестник РАМН. - 2005. - № 1. - С. 3-8.
Панафидина Т. А. Интеpлейкин-18 пpи системной кpасной волчанке: связь с клиническими пpоявлениями заболевания и атеpосклеpотическим поpажением сосудов / Т. А. Панафидина, Т. В. Попкова, З. С. Алекбеpова [и др.] // Терапевтический архив. - 2008. - № 5. – С. 15–20.
Синяченко О. В. Эндотелиальная дисфункция при гломерулонефрите / О. В. Синяченко, С. В. Зяблицев, П. А. Чернобривцев - Донецк : 000 «Новый мир», 2006. – 152 с. – 500 экз. – ISBN 966-108-13-8.
Старикова З. А. Изменения поверхностного фенотипа зндотелиальных клеток под влиянием провоспалительных и противовоспалительных цитокинов / З. А. Старикова [и др.] // Медицинская иммунология. - 2003. - Т. 5, № 1-2. - С. 39-48.
Хрипко О. П. Аллельный полиморфизм гена интерлейкина-18 и использование дендритных клеток и интерлейкина-18 для модуляции иммунного ответа при хроническом вирусном гепатите в in vitro : автор. … канд. биол. наук : 14.00.36 / О. П. Хрипко. - Новосибирск, 2008. – 20 с.
Annunziato F. Phenotypic and functional features of human Th17 cells / F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi [et al.] // J. Exp. Med. – 2007. - V. 204. –– P. 1849–1861.
Banfi G. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study/ Banfi G, Moriggi, M, Sabadini, E, et al.// Clin Nephrol. – 1991. – V. 36. – P.53-59
Bell E. Immune regulation : New player in the generation of TH17 cells / E. Bell // Nature Reviews Immunology. – 2007. – Р. 581. - doi:10.1038/nri 2139.
Bettelli E. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells / E. Bettelli, Y. Carrier, W. Gao , T. Korn [et al.] // Nature. - 2006. - 7090. – P. 235–238.
Bissonnette E. Y. TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway / E. Y. Bissonnette [et al.] // Am. J. Respir. Cell. Mol. Biol. – 1997. – Vol. 16, N 3. – P. 275-282.
Chabdan S. H. Interleukin-10 differentially modulates MHC class II expression mesangial cells and macrophages in vitro and in vivo / S. H. Chabdan [ et al ] // Immunology. - 1998. - № 9. - P. 72-78.
Charles A. D. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process / F. D. Charles // American Journal of Clinical Nutrition – 2006. - Vol. 83. - No. 2. – P. 447S - 455S.
Chun, MJ. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants/ Chun MJ, Korbet SM, Schwartz MM, Lewis EJ// J. Am. Soc. Nephrol. – 2004. – V.15. – P.2169-2177
Cooke A. Th17 Cells in Inflammatory Conditions / A. Cooke // Rev. Diabet. Stud. – 2006. – 3 (2). - Р. 72-75.
D'Amico G. Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage / G. D'Amico// Nephrol. Dial. Transplant. - 1998. - Vol. 13, Suppl. 1. - P. S80-S85.
Floege J. Present and future therapy options in IgA-nephropathy. /Floege J, Eitner F.// J. Nephrol. - 2005.- 18:354.
Gracie J. A. Interleukin-18 / J. A. Gracie, S. E. Robertson, I. B. McInnes // J Leukoc Biol. - 2003. – 73 (2). – P. 213-224.
Gupta S. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis / S. Gupta [et al.] // Kidney Int. - 2000. – Vol. 58. – P. 1389-1399.
Heering P. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis/ Heering P., Braun, N, Müllejans, R, et al. //Am J Kidney Dis. - 2004. – V. 43. – P.10-18
Huang Y. Renin-stimulated TGF-β1 expression is regulated by a mitogen- activated protein kinase in mesangial cells / Y. Huang [et al.] // Kidney International. – 2007. – 72. - Р. 45–52.
Jha V. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy / Jha V, Ganguli A, Saha TK, et al.// J. Am. Soc. Nephrol.- 2007.- 18:1899.
Khader S. A. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge / S. A. Khader, G. K. Bell, J. E. Pearl [et al.] // Nat. Immunol. – 2008. - 8.- P. 369–377.
Komiyama Y. IL Role in-17 plays an important the development of experimental autoimmune encephalomyelitis. / Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu [et al.] // J. Immunol. – 2006. – 177. – P. 566-573.
Levey A. S. Chronic kidney disease as a global public health problem : Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes / A. S. Levey, R. Atkins, J. Coresh [et al.] // Kidney International. – 2007. – 72. – P. 247–259.
Lubberts E. The role of IL-17 and family members in the pathogenesis of arthritis / E. Lubberts // Curr. Opin. Investig. – 2003. - 4. – P. 572-577.
Lubberts E. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion / E. Lubberts, M. I. Koenders, B. Oppers-Walgreen, L. van den Bersselaar [et al.] // Arthritis Rheum. – 2004. – V. 50. – P. 650–659.
Mangan P. R. Transforming growth factor-beta induces development of the T(H)17 lineage / P. R. Mangan, L. E. Harrington, D. B. O'Quinn, W.S. Helms [et al.] // Nature. – 2006. – 441. – P. 231-234.
Nakanishi K. Interleukin-18 regulates both Th1 and Th2 responses / K. Nakanishi, T. Yoshimoto, H. Tsutsui, H. Okamura // Annu Rev Immunol. - 2001. – V. 19. - P. 423-474.
Ning-ning S. High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura / S. Ning-ning, Z. Xiao-juan, W. Qian, W. Chun-yan [et al.] // Haematologica. - 2009. – Vol. 94, Issue 11. – P. 1603-1607.
Ouyang W. The biological functions of T helper 17 cell effector cytokines in inflammation / W. Ouyang, J. K. Kolls, Y. Zheng // Immunity. - 2008. - Apr. 28. - № 4. – Р. 454-467.
Ritz E. The role of vasoactive compounds, growth factors and cyotkines in the progression of renal disease / E. Ritz, M. Schomig, J. Wagner // Kidney Int. - 2000. - Vol. 57, Suppl. 75. - P. 71-76.
Sugama S. Interleukin-18 and stress / S. Sugama, B. Conti // Brain research reviews. – 2008. - 58 (1). – P. 85–95.
Tzartos J.S. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis / J. S. Tzartos, M. A. Friese, M. J. Craner, J. Palace [et al.] // Am. J. Pathol. – 2008. – 172. – P. 146-155.
Walker Lucy S. K. CD4+ CD25+ Treg : divide and rule? / Lucy S. K. Walker // Immunology. – 2007. - Vol. 111, Issue 2. - P. 129-132.
Wang W. Transforming growth factor-beta and Smad signalling in kidney diseases / W. Wang, V. Koka, H. Y. Lan // Nephrology. – 2005. - 10. – Р. 48–56.
Yen D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 / D. Yen [et al.] // J. Clin. Invest. - 2006. - 116 (5). - Р. 1310-1316.
Zheng Y. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis / Y. Zheng, D. M. Danilenko, P. Valdez, I. Kasman // Eastham Nature. – 2009. - Vol. 445. – P. 648-651.
